Quarterly report pursuant to Section 13 or 15(d)

12. Segments

v3.8.0.1
12. Segments
9 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Segments

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

 

The following tables set forth certain information regarding our segments:

 

    Nine Months Ended December 31,  
    2017     2016  
Revenues:            
Aethlon   $ 74,813     $ 392,073  
ESI            
Total Revenues   $ 74,813     $ 392,073  
                 
Operating Losses:                
Aethlon   $ (3,495,189 )   $ (4,478,631 )
ESI     (64,860 )     (115,443 )
Total Operating Loss   $ (3,560,049 )   $ (4,594,074 )
                 
Net Losses:                
Aethlon   $ (4,308,807 )   $ (5,497,978 )
ESI     (64,860 )     (115,443 )
Net Loss Before Non-Controlling Interests   $ (4,373,667 )   $ (5,613,421 )
                 
Cash:                
Aethlon   $ 5,610,061     $ 625,531  
ESI     738       3,084  
Total Cash   $ 5,610,799     $ 628,615  
                 
Total Assets:                
Aethlon   $ 5,745,031     $ 752,578  
ESI     5,723       37,019  
Total Assets   $ 5,750,754     $ 789,597  
                 
Capital Expenditures:                
Aethlon   $ 23,705     $ 2,961  
ESI            
Capital Expenditures   $ 23,705     $ 2,961  
                 
Depreciation and Amortization:                
Aethlon   $ 27,402     $ 16,322  
ESI           10,043  
Total Depreciation and Amortization   $ 27,402     $ 26,365  
                 
Interest Expense:                
Aethlon   $ (306,495 )   $ (115,308 )
ESI            
Total Interest Expense   $ (306,495 )   $ (115,308 )